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Background
Obstetric antiphospholipid antibody syndrome (OAPS) is associated with adverse pregnancy outcomes. A systematic review (2004) demonstrated diversity in published studies, making it difficult to interpret the outcomes in various subgroups with OAPS.
Clinicians (and patients) are divided about the efficacy of any treatment, given the heterogeneity of the patient populations studied, endpoints, outcome measures reported and treatments used. Many of these patients are being cared for by their rheumatologist, haematologist, obstetrician and fertility specialistswho may have different recommendations concerning the need for lowmolecular weight heparin (LMWH). Women who have sought fertility treatment are finding it difficult to discontinue their LMWH despite the lack of evidence for its efficacy. The lack of consensus on therapeutic measures between various clinical specialities and patients often leads to poor patient experience. Patient involvement in the decision making process in these studies have not been reported; it could be the prime motivation for clinicians to continue prescribing LMWH despite the lack of demonstrable efficacy. Hence we need to develop a core outcome set so that clinicians from various subspecialities and patients will be able to assess each of these studies in a standardised fashion. 
Results
This proposed project is in the preparation stage. International collaboration with various subspecialties is planned. This project will benefit from the support and recommendations of COMET initiative experts.
Conclusion
A consensus on core outcome set for reporting for OAPS, involving clinicians across various subspecialties (rheumatology, obstetrics, maternal-fetal medicine, fertility and haematologists) and the patients is essential for studying the effectiveness of various treatment modalities.
